Search HSIC
HENRY SCHEIN INC
Nasdaq · CIK 1000228
Last close84.88
Daily change-0.05 (-0.06%)
10 Years gain+34.08%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
HSIC · STANDARD
SIC 5047 · Wholesale-Medical, Dental & Hospital Equipment & Supplies · Fiscal year end 1226
Fundamental
39.6Momentum
49.6Acceleration
49.1Confidence
91.0Annual Revenue18
Quarterly Revenue78
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth4.9 / 25
Quality13.6 / 25
Capital Efficiency4.2 / 20
Balance Sheet6.1 / 15
Shareholder Economics10.0 / 10
Forward Indicators0.8 / 5
Signals
Share count reductionDiluted share count declined 8.3765%.
Key Metrics
Revenue Growth TTM5.97%OK
Revenue CAGR 3Y1.4%OK
Gross Margin31.43%OK
Operating Margin4.98%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC13.07%OK
Incremental Operating Margin 3Y-20.65%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-8.38%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 27, 2025 | $13.18B | $4.11B | $653.00M | $712.00M | $573.00M | 31.14% | 4.95% | 4.35% | 13.27% | 121.72M |
| 2025 FY Dec 28, 2024 | $12.67B | $4.02B | $621.00M | $848.00M | $700.00M | 31.69% | 4.9% | 5.52% | 12.79% | 127.78M |
| 2025 FY Dec 30, 2023 | $12.34B | $3.86B | $615.00M | $500.00M | $353.00M | 31.28% | 4.98% | 2.86% | 11.96% | 131.75M |
| 2024 FY Dec 31, 2022 | $12.65B | $3.83B | $747.00M | $602.00M | $506.00M | 30.29% | 5.91% | 4% | 13.88% | 137.76M |
| 2023 FY Dec 25, 2021 | $12.40B | $3.67B | $852.00M | $710.00M | $631.00M | 29.63% | 6.87% | 5.09% | 18.88% | 141.77M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $13.41B | sum latest 4 fiscal quarters Revenue | OK | 0001000228-26-000045, 0001000228-25-000066 |
| Revenue Growth TTM | 5.97% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001000228-26-000045, 0001000228-25-000066 |
| Revenue CAGR 3Y | 1.4% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001000228-26-000013 |
| Revenue CAGR 5Y | 5.43% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001000228-26-000013 |
| Gross Profit CAGR 3Y | 2.33% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001000228-26-000013 |
| Operating Income Growth | 4.21% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001000228-26-000045, 0001000228-25-000066 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 31.43% | Gross Profit / Revenue | OK | 0001000228-26-000045, 0001000228-25-000066 |
| Operating Margin | 4.98% | Operating Income / Revenue | OK | 0001000228-26-000045, 0001000228-25-000066 |
| ROIC | 13.07% | NOPAT / Average Invested Capital | OK | 0001000228-26-000045, 0001000228-25-000066 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001000228-26-000045 |
| Interest Coverage | 4.23x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 1.32x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.15x | (Cash + Short-term Investments) / Total Debt | OK | 0001000228-26-000045 |